Home/ Supplements/ Feverfew/ Migra-None

Migra-None

product on market Capsule Douglas Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

Feverfew and ginger are utilized for their potential to reduce the frequency and severity of migraine symptoms. Research provides moderate evidence for the efficacy of feverfew in prophylaxis, while ginger is often studied for acute relief. Overall evidence coverage for this specific combination remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Migra-None
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Botanical
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

250 mg
Market median: 380.0mg (120 products) 8 studies — no high-quality reviews
125 mg
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)

Other Ingredients

Gelatin Cellulose Silica Vegetable Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Usage: As a dietary supplement, adults take 1 capsule 1 to 2 times daily or as directed by your healthcare professional.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Tamper resistant package, do not use if outer seal is missing.

Formulation Notes

This product contains NO yeast, wheat gluten, soy protein, milk/dairy, corn, sodium, sugar, starch, artificial coloring, preservatives or flavoring.

Additional Information

For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/15(0)-25(0)C) (35-65% relative humidity)

Formula #83033

Metadata

Product Details

UPC / SKU3 10539 83033 8
DSLD Entry Date2012-06-25
Product TypeBotanical
FormCapsule
BrandDouglas Laboratories
DSLD ID10131
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
48
Avg Quality
4
Systematic Review
4
Rct
1
Meta Analysis
1
Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988 PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009 PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006 PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012 PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004 PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998 PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985 PubMed
View all evidence for Feverfew →
Compare

Similar Products

White Willow Feverfew 350 mg
Eclectic Herb · Capsule
100
Feverfew
GNC Herbal Plus Standardized · Capsule
100
Feverfew
Vitabase · Capsule
100
Feverfew Max-V
Douglas Laboratories · Capsule
100
Migra-X
OL Olympian Labs · Capsule
100
View all Feverfew products →
Feverfew research Best Feverfew All Feverfew products More from Douglas Laboratories View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.